A Case of Secondary HLH Activated by Acute Pancreatitis (ACG 2026) - Aug 29, 2026 - Abstract #P2476; Pres time: Oct 12, 2026; 10:30 AM - 04:15 PM; Location: Exhibit Halls A - D (Level 3); "Etoposide and ruxolitinib were deferred given concern for organ dysfunction and infection risk. He improved clinically and was discharged on a dexamethasone taper...The HScore can aid risk stratification. A high index of suspicion is key, as early diagnosis and treatment are critical to improving survival."
Clinical • Addiction (Opioid and Alcohol) • Dyslipidemia • Febrile Neutropenia • Hemophagocytic lymphohistiocytosis • Hypertriglyceridemia • Immunology • Infectious Disease • Pancreatitis • Rare Diseases • Renal Disease • CXCL9 • IL18 • IL2
|
|
Alyssa Martin MD 1; Mary Kate Sullivan MD 1; Chloe Hundman MD 1; Amy Doran MD 2
|